scholarly journals Imaging of benign solitary fibrous tumor of the pleura: a pictorial essay

Rare Tumors ◽  
2010 ◽  
Vol 2 (1) ◽  
pp. 1-4 ◽  
Author(s):  
Luciano Cardinale ◽  
Francesco Ardissone ◽  
Irene Garetto ◽  
Valerio Marci ◽  
Giovanni Volpicelli ◽  
...  

Solitary fibrous tumor of the pleura (SFTP) is a mesenchymal tumor that tends to involve the pleura, and is also described in other thoracic and extrathoracic sites. SFTP usually presents as a peripheral mass abutting the pleural surface, to which it is attached by a broad base or by a pedicle that allows it to be mobile. SFTPs exist in benign and malignant forms. A precise pre-operative diagnosis can be arrived at with a cutting-needle biopsy, although most cases are diagnosed with postoperative histology and immunohistochemical analysis. In this pictorial essay, we review a large series of cases, with emphasis on the radiographic appearance of these lesions and their findings from computed tomography, magnetic resonance imaging, ultrasonography and positron emission tomography.

2020 ◽  
Vol 25 (4) ◽  
pp. 3824
Author(s):  
Д. A. Sarachan ◽  
A. V. Skrebtsov ◽  
E. A. Zakharyan ◽  
Д. S. Sobinov

The review is dedicated to such a rare disease as primary cardiac angiosarcoma (PCA). The following imaging methods are used for its diagnosing: transthoracic and transesophageal echocardiography, computed tomography, positron emission tomography and magnetic resonance imaging. To verify the diagnosis, a biopsy with cytological and immunohistochemical analysis is performed. The symptoms of PCA is non-specific and often manifests itself only in the late stages, which leads to a significant deterioration of prognosis. Treatment of PCA requires a multifaceted approach. It mainly involves the achievement of a curative resection (R0 resection). Regarding chemotherapy, neoadjuvant therapy with doxorubicin and ifosfamide is effective. In addition to these agents, cyclophosphamide, anthracycline, vincristine and others are used. Today, the use of targeted therapy with imatinib, sorafenib, pazopanib, and bevacizumab is promising. However, it requires further analysis. The article also describes other therapy methods using a beta-blockers and radiation exposure.


1996 ◽  
Vol 35 (03) ◽  
pp. 102-104 ◽  
Author(s):  
E. U. Nitzsche ◽  
J. J. Laubenberger ◽  
Almut Einert ◽  
E. Moser ◽  
G. H. Simon

SummaryMedullary carcinoma of the thyroid gland is a rare tumor. Its prognosis is mainly linked to surgery, because there is no valid alternative therapy to improve patients outcome. In this report, we discuss the recurrence of such a tumor in a 64-year-old female, focusing on magnetic resonance imaging and positron emission tomography evaluation of this tumor.


Sign in / Sign up

Export Citation Format

Share Document